iNOS Aggresome as a Prototype of a Physiologic Aggresome

iNOS Aggresome 作为生理 Aggresome 的原型

• 批准号: 7034438
• 负责人: N. Tony Eissa
• 金额: $ 37.5万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-05-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7034438
• 关键词: alpha 1 antitrypsin deficiency; bronchoscopy; clinical research; cystic fibrosis; emphysema; human subject; interstitial lung diseases; lung disorder; nitric oxide synthase; pathologic process; posttranslational modifications; proteasome; protein degradation; protein folding; protein protein interaction; protein structure function; protein transport; respiratory epithelium; tissue /cell culture

DESCRIPTION (provided by applicant): Misfolding of proteins plays an important part in the pathogenesis of several lung diseases. Misfolded and aggregated proteins are handled in the cell through chaperone-mediated refolding, or destroyed by proteasomal degradation. Recent evidence suggests that cells have evolved a third pathway that involves sequestration of misfolded proteins into specialized "holding stations", close to the nucleus, called aggresomes. Recognizing the importance of this topic, the NHLBI convened a workshop to review protein processing related issues. The workshop emphasized the need for understanding the nature and the role of aggresome and the cellular mechanisms of its formation. We have discovered that cells regulate inducible nitric oxide synthase (iNOS) through aggresome formation. This newly discovered iNOS aggresome is the first described occurrence of an aggresome that is not associated with protein misfolding and which we termed "physiologic aggresome". This discovery sets the stage for a unique research opportunity. Study of the physiologic aggresome should reveal a wealth of information regarding how cells regulate proteins through aggresome formation. We hypothesize that: A) iNOS physiologic aggresome shares certain features with what previously described as "pathologic" aggresome associated with misfolded proteins. Thus, pathologic aggresome may merely represent an acceleration of an established physiologic regulatory process. B) The regulation of aggresome formation in cells is linked to cell capacity to degrade proteins in a timely manner. Whenever cells sense that this capacity is likely to be exceeded due to the generation of either a misfolded protein or a large amount of a certain protein, they trigger aggresome formation. The decision of cells to resort to aggresome formation results in specific proteins migrating to participate in the formation and the regulation of the aggresome. To test these hypotheses we propose studies with the following specific aims: 1) Characterization of mechanisms of formation and regulation of iNOS aggresome. 2) Identification of proteins forming iNOS aggresome. 3) Examination of the regulation of iNOS aggresome in cells harboring misfolded mutant proteins related to lung disease such as a1-antitrypsin mutants. The rationale for the proposed studies is that once these mechanisms are understood, they would greatly increase our understanding of cellular handing of misfolded proteins. Future therapeutic strategies can be designed to regulate these cellular responses in disease states.

描述（由申请人提供）：蛋白质的错误折叠在几种肺部疾病的发病机制中起重要作用。错误折叠和聚集的蛋白质在细胞中通过分子伴侣介导的重折叠进行处理，或通过蛋白酶体降解被破坏。最近的证据表明，细胞已经进化出第三条途径，该途径涉及将错误折叠的蛋白质隔离到靠近细胞核的专门的“保持站”，称为侵略者。认识到这一主题的重要性，NHLBI召开了一个研讨会，审查蛋白质加工相关问题。讲习班强调需要了解侵略性基因组的性质和作用及其形成的细胞机制。我们已经发现细胞通过侵袭体的形成来调节诱导型一氧化氮合酶（iNOS）。这个新发现的iNOS攻击组是第一个描述的攻击组的发生，与蛋白质错误折叠无关，我们称之为“生理攻击组”。这一发现为独特的研究机会奠定了基础。对生理性攻击组的研究应该揭示关于细胞如何通过攻击组形成调节蛋白质的丰富信息。我们假设：A）iNOS生理性攻击基因组与先前描述的与错误折叠蛋白质相关的“病理性”攻击基因组共享某些特征。因此，病理性攻击基因组可能仅仅代表了一个已建立的生理调节过程的加速。B）细胞中攻击体形成的调节与细胞及时降解蛋白质的能力有关。每当细胞感觉到由于错误折叠蛋白质或大量某种蛋白质的产生而可能超过这种能力时，它们就会触发攻击体的形成。细胞决定求助于攻击体形成导致特定蛋白质迁移以参与攻击体的形成和调节。为了验证这些假设，我们提出了以下具体目标的研究：1）表征iNOS攻击体的形成和调节机制。2)鉴定形成iNOS侵袭体的蛋白质。3)在携带与肺病相关的错误折叠突变蛋白如α 1-抗胰蛋白酶突变体的细胞中检测iNOS侵袭体的调节。提出研究的理由是，一旦这些机制被理解，它们将大大增加我们对错误折叠蛋白质的细胞处理的理解。未来的治疗策略可以被设计为调节疾病状态下的这些细胞反应。